<DOC>
	<DOCNO>NCT01329068</DOCNO>
	<brief_summary>Carriers BRCA mutation significantly increase risk develop breast cancer course life . They face difficult choice : either preventive removal breast ( ) intensive inspection process . After primary treatment breast cancer , patient follow 5-10 year diagnose recurrence new primary tumor early stage ; support patient hormonal treatment ; educate patient risk factor healthy life style ; provide psychosocial support . Currently , follow-up breast cancer patient surveillance BRCA mutation carrier offer regular , one-to-one medical visit . Experience show individual visit often possible give aspect important , enough attention . The group medical consultation ( GMC ) new form medical visit physician nurse practitioner performs series one-to-one consultation presence 8 to10 patient . A social worker accompanies process . Patients group consultation may gather information learn relatively time compare regular consultation . Research show patient caregiver satisfy care group consultation compare individual visit . After GMC participant breast cancer GMCs provide dedicate iPad 3 month . Using iPad , patient contact woman meet GMC well health care professional several communication channel , include virtual group meeting . This approach provide unique combination social support professional education concern survivorship e-health environment.However , also know group session may counterproductive patient , example frighten story others . The goal study examine whether group visit ( combination dedicate iPads ) beneficial woman BRCA mutation patient follow-up breast cancer .</brief_summary>
	<brief_title>Patient Empowerment Group Medical Consultations</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Participants : patient followup breast cancer Women ≥ 18 year age histologically proven breast cancer . Primary treatment ( surgery , radiotherapy , chemotherapy ) complete maximally 5 year ago . Participants : woman BRCA mutation Women ≥ 25 year age proven BRCA1 BRCA2 mutation . Carrier BRCA1 BRCA2 mutation , diagnose maximally two year inclusion . Participants : patient followup breast cancer Metastatic breast cancer Currently involve diagnostic workup suspicion breast cancer , either primary metastatic . A history prophylactic mastectomy . Current psychiatric disease preclude consultation group . Insufficient command Dutch language able follow group discussion and/or fill Dutch questionnaire Participants : woman BRCA mutation Metastatic breast cancer Currently involve diagnostic workup suspicion breast cancer , either primary metastatic . A history prophylactic mastectomy . Current psychiatric disease preclude consultation group . Insufficient command Dutch language able follow group discussion and/or fill Dutch questionnaire</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>breast cancer</keyword>
</DOC>